Lieferengpass bei Antibiotikum: Pivmecillinam – ein erfreulicher Engpass?
Antibiotika bei Harnwegsinfektionen - Arzneimittelkommission der deutschen Ärzteschaft
Emcil - Square Pharmaceuticals Ltd.
Wirkstoff AKTUELL - Ausgabe 3/2017
pivmecillinam hydrochloride
Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplic
Pivmecillinam in the Treatment of Infections A Comparison with Pivmecillinam , Pivampicillin Therapy Resistant Urinary Tract and Their Combination Summary : | Semantic Scholar
Three versus five days of pivmecillinam for community-acquired uncomplicated lower urinary tract infection: A randomised, double-blind, placebo-controlled superiority trial - eClinicalMedicine
High Dose Pivmecillinam Effective for UTIs Caused by Resistant Escherichia coli - Infectious Disease Advisor
Pivmecillinam: - No dose change is required in mild to moderate CKD. Pivmecillinam may be used as an alternative in the manageme
Optimal dosage and duration of pivmecillinam treatment for uncomplicated lower urinary tract infections: a systematic review and meta-analysis - ScienceDirect
Efficacy of mecillinam against clinical multidrug-resistant Escherichia coli in a murine urinary tract infection model - ScienceDirect